Neurologic Disorders
ACCELERATION-DECELERATION INJURIES
Acceleration-deceleration cervical injuries (commonly known as whiplash) result from sharp hyperextension and flexion of the neck that damages muscles, ligaments, disks, and nerve tissue. The prognosis for this type of injury is usually excellent; symptoms usually subside with treatment of symptoms.
Causes
Motor vehicle and other transportation accidents
Falls
Sports-related accidents
Crimes and assaults
Pathophysiology
The brain is shielded by the cranial vault (hair, skin, bone, meninges, and cerebrospinal fluid [CSF]), which intercepts the force of a physical blow. Below a certain level of force (the absorption capacity), the cranial vault prevents energy from affecting the brain. The degree of traumatic head injury usually is proportional to the amount of force reaching the cranial tissues. Furthermore, unless ruled out, neck injuries should be presumed present in patients with traumatic head injury.
In acceleration-deceleration cervical injuries, the head is propelled in a forward and downward motion in hyperflexion. A wedge-shaped deformity of the bone may be created if the anterior portions of the vertebrae are crushed. Intervertebral disks may be damaged; they may bulge or rupture, irritating spinal nerves. Then the head is forced backward. A tear in the anterior ligament may pull pieces of bone from cervical vertebrae. Spinous processes of the vertebrae may be fractured. Intervertebral disks may be compressed posteriorly and torn anteriorly. Vertebral arteries may be stretched, pinched, or torn, causing reduced blood flow to the brain. Nerves of the cervical sympathetic chain may also be injured.
A complex arrangement of ligaments holds the vertebrae in place. Some of the ligaments are barely a centimeter long, and all are only a few millimeters thick. In a whiplash injury, ligaments may be badly stretched, partially torn, or completely ruptured (arrows). Injuries of neck muscles may range from minor strains and microhemorrhages to severe tears. The anterior longitudinal ligament, running vertically along the anterior surface of the vertebrae, may be injured during hyperextension. The posterior longitudinal ligament, running on the posterior surface of the vertebral bodies, may be injured in hyperflexion. The broad ligamentum nuchae may also be stretched or torn.
Closed trauma is typically caused by a sudden accelerationdeceleration or coup/contrecoup injury. In coup/contrecoup, the head hits a relatively stationary object, injuring cranial tissues near the point of impact (coup); then the remaining force pushes the brain against the opposite side of the skull, causing a second impact and injury (contrecoup). Contusions and lacerations may also occur during contrecoup as the brain’s soft tissues slide over the rough bone of the cranial cavity. In addition, rotational shear forces on the cerebrum may damage the upper midbrain and areas of the frontal, temporal, and occipital lobes.
Signs and Symptoms
Although symptoms may develop immediately, they may be delayed 12 to 24 hours if the injury is mild. Whiplash produces moderate to severe anterior and posterior neck pain. Within several days, the anterior pain diminishes, but the posterior pain persists or even intensifies, causing patients to seek medical attention.
Whiplash may also cause:
dizziness and gait disturbances
vomiting
headache, nuchal rigidity, and neck muscle asymmetry
rigidity or numbness in the arms.
Diagnostic Test Results
X-ray of the cervical spine will determine that vertebral injury hasn’t occurred.
CLINICAL TIP
In all suspected spinal injuries, assume that the spine is injured until proven otherwise. Any patient with suspected whiplash or other injuries requires careful transportation from the accident scene. To do this, place the patient in a supine position on a spine board and immobilize the neck with tape and a hard cervical collar or sandbags. New literature suggests a hard board is not necessary.
Until an X-ray rules out a cervical fracture, move the patient as little as possible. Before the X-ray is taken, carefully remove any ear and neck jewelry. Don’t undress the patient; cut clothes away, if necessary. Warn the patient against movements that could injure the spine. Patients need to be medically evaluated by trained clinicians prior to removal of collar.
Treatment
Immobilization with a soft, padded cervical collar for several days or weeks
Ice or cool compresses to the neck for the first 24 hours, followed by moist, warm heat thereafter
Over-the-counter analgesics, such as acetaminophen or ibuprofen
Muscle relaxants
In severe muscle spasms, consider referral to physical therapy
ALZHEIMER’S DISEASE
Alzheimer’s disease is a progressive degenerative disorder of the cerebral cortex, especially the frontal lobe. It affects approximately 5 million Americans; by 2030, that figure may reach 7.7 million. It’s the seventh-leading cause of death in the United states.
The disease has a poor prognosis. Typically, the duration of illness is 8 years, and patients die 2 to 5 years after the onset of debilitating brain symptoms.
Causes
Exact cause unknown
Possible Contributing Factors
Genetic patterns
Beta-amyloid plaque development
Inflammatory and oxidative stress processes
The role of estrogen in the brain
Pathophysiology
The brain of a patient with Alzheimer’s disease has three characteristic features: neurofibrillary tangles (fibrous proteins), neuritic plaques (composed of degenerating axons and dendrites), and neuronal loss (degeneration).
Neurofibrillary tangles are bundles of filaments found inside neurons that abnormally twist around one another. Abnormally phosphorylated tau proteins accumulate in the neurons as characteristic tangles and ultimately cause neuronal death. In a healthy brain, tau provides structural support for neurons, but in patients with Alzheimer’s disease, this structural support collapses.
Neuritic plaques (senile plaques) form outside the neurons in the adjacent brain tissue. Plaques contain a core of beta-amyloid protein surrounded by abnormal nerve endings or neurites. Overproduction or decreased metabolism of betaamyloid peptide leads to a toxic state causing degeneration of neuronal processes, neuritic plaque formation, and eventually neuronal loss and clinical dementia.
Tangles and plaques cause neurons in the brain of the patient with Alzheimer’s disease to shrink and eventually die, first in the memory and language centers and finally throughout the entire brain. This widespread neuron degeneration leaves gaps in the brain’s messaging network that may interfere with communication between cells, causing some of the symptoms of Alzheimer’s disease.
Signs and Symptoms
Mild
Disorientation to date
Impaired recall
Diminished insight
Irritability
Apathy
Moderate
Increased disorientation (time and place)
Fluent aphasia
Difficulties with comprehension
Impaired recognition
Poor judgment
Trouble performing activities of daily living (ADLs)
Aggression
Restlessness
Psychosis
Sleep disturbances
Dysphoria
Severe
Unable to use language appropriately
Memory only to the moment
Needs assistance with all ADLs
Urinary and fecal incontinence
Diagnostic Test Results
Neuropsychologic evaluation shows deficits in memory, reasoning, vision-motor coordination, and language function.
Magnetic resonance imaging or computed tomography scan reveals brain atrophy at later stages of the disease.
Positron emission tomography scanning shows decreased brain activity.
EEG shows evidence of slowed brain waves at later stages of the disease.
AMYOTROPHIC LATERAL SCLEROSIS
Commonly called Lou Gehrig’s disease, after the New York Yankees first baseman who died of this disorder, amyotrophic lateral sclerosis (ALS) is the most common of the motor neuron diseases causing muscular atrophy. A chronic, progressively debilitating disease, ALS may be fatal in less than 1 year or continue for 10 years or more, depending on the muscles affected. More than 30,000 Americans have ALS; the disease affects three times as many men as women.
Causes
The exact cause is unknown. A genetic (familial ALS “FALS”) link is seen in 10% of all ALS cases. A specific gene mutation in an enzyme known as superoxide dismutase 1 has been identified in about 20% of FALS cases. Over 90% of cases of ALS occur randomly with no identifiable cause and no risk factors and are referred to as sporadic ALS. Several theories have been proposed that explain why motor neurons die, including:
glutamate excitotoxicity
oxidative injury
protein aggregates
axonal strangulation
autoimmune-induced calcium influx
viral infections
deficiency of nerve growth factor
apoptosis (programmed cell death)
trauma
environmental toxins.
Pathophysiology
Current research suggests an excess accumulation of glutamate (an excitatory neurotransmitter) in the synaptic cleft. The affected motor units are no longer innervated, and progressive degeneration of axons causes loss of myelin. Some nearby motor nerves may sprout axons in an attempt to maintain function, but, ultimately, nonfunctional scar tissue replaces normal neuronal tissue.
Signs and Symptoms
Fasciculations, spasticity, atrophy, weakness, and loss of functioning motor units (especially in forearms and hands)
Impaired speech, chewing, and swallowing; choking; drooling
Difficulty breathing, especially if the brain stem is affected
Muscle atrophy
Reactive depression
Diagnostic Test Results
Electromyography shows abnormalities of electrical activity in involved muscles.
Muscle biopsy shows atrophic fibers interspersed between normal fibers.
CSF analysis by lumbar puncture reveals elevated protein levels.
Nerve conduction studies show normal results.
ARTERIOVENOUS MALFORMATION
Arteriovenous malformations (AVMs) are tangled masses of thin-walled, dilated blood vessels between arteries and veins that aren’t connected by capillaries. AVMs are common in the brain, primarily in the posterior portion of the cerebral hemispheres. Abnormal channels between the arterial and venous system mix oxygenated and unoxygenated blood and thereby prevent adequate perfusion of brain tissue.
AVMs range in size from a few millimeters to large malformations extending from the cerebral cortex to the ventricles. Usually, more than one AVM is present. Males and females are equally affected. Some evidence exists that AVMs occur run in families.
Causes
Congenital: hereditary defect
Acquired: trauma such as penetrating injuries
Pathophysiology
AVMs lack the typical structural characteristics of the blood vessels. The vessel walls of an AVM are very thin; one or more arteries feed into the AVM, causing it to appear dilated and torturous. The typically high-pressured arterial flow moves into the venous system through the connecting channels to increase venous pressure, engorging and dilating the venous structures. An aneurysm may develop. If the AVM is large enough, the shunting can deprive the surrounding tissue of adequate blood flow. Additionally, the thin-walled vessels may ooze small amounts of blood or actually rupture, causing hemorrhage into the brain or subarachnoid space.
Signs and Symptoms
Typically, few or none.
If AVM Is Large, Leaks, or Ruptures
Chronic headache and confusion
Seizures
Systolic bruit over carotid artery, mastoid process, or orbit
Focal neurologic deficits (depending on the location of the AVM)
Hydrocephalus
Paralysis
Loss of speech, memory, or vision
Diagnostic Test Results
Cerebral arteriogram confirms the presence of AVMs and evaluates blood flow.
Doppler ultrasonography of the cerebrovascular system indicates abnormal, turbulent blood flow.
BELL’S PALSY
Bell’s palsy is a disease of the facial nerve (cranial nerve VII) that produces unilateral or bilateral facial weakness. Onset is rapid. In 80% to 90% of patients, it subsides spontaneously and recovery is complete in 1 to 8 weeks. If recovery is partial, contractures may develop on the paralyzed side of the face. Bell’s palsy may recur on the same or opposite side of the face.
Causes
Infection such as herpes simplex virus
Tumor
Meningitis
Local trauma
Lyme disease
Hypertension
Sarcoidosis
Pathophysiology
Bell’s palsy reflects an inflammatory reaction around the seventh cranial nerve, usually at the internal auditory meatus where the nerve leaves bony tissue. The characteristic unilateral or bilateral facial weakness results from the lack of appropriate neural stimulation to the muscle by the motor fibers of the facial nerve.
Signs and Symptoms
Unilateral face weakness
Aching at jaw angle
Drooping mouth
Distorted taste or loss of taste
Impaired ability to fully close the eye on the affected side
Tinnitus
Excessive or insufficient eye tearing on the affected side
Hypersensitivity to sound on the affected side
Headache
Diagnostic Test Results
Diagnosis is based on clinical presentation. (See Diagnosing Bell’s Palsy.) Other studies include:
nerve conduction studies and electromyography to determine the extent of nerve damage
blood tests to establish the presence of sarcoidosis or Lyme disease.
BRAIN TUMORS
Brain tumors are abnormal growths that develop after transformation of cells within the brain, cerebral vasculature, or meninges. They’re usually referred to as benign or malignant. Malignancy in the brain is graded on the degree of cellularity, endothelial proliferation, nuclear atypia, and necrosis. Highly malignant brain tumors are aggressive tumors that grow and multiply rapidly. Survival and prognosis are directly related to tumor grade. However, even though benign tumors lack aggressiveness, they can be as devastating neurologically depending on their size and location. The most common types of primary brain tumors are gliomas, meningiomas, and pituitary adenomas.
Causes
Unknown in most cases
A genetic loss or mutation
Prior cranial radiation exposure
Pathophysiology
At the level of the cell nucleus, both positive and negative regulators of growth are necessary for normal control of cell proliferation. The positive regulators, protooncogenes, have products that function as growth factors, growth factor receptors, and signaling enzymes. Excessive production may occur that converts protooncogenes into oncogenes, resulting in significant neoplastic growth.
Negative regulators of cell growth are called tumor suppressor genes. Suppressor genes inhibit cellular proliferation at the level of the nucleus. The loss of tumor suppressor genes by mutation, deletion, or reduced expression aids in the conversion of normal cells to malignant phenotypes. The excessive stimulation of proto-oncogenes and the lack of inhibition of tumor suppressor genes ultimately lead to neoplastic proliferation. As the tumor grows, edema develops in surrounding tissues and intracranial pressure (ICP) increases. As the tumor continues to grow, it may interfere with the normal flow and drainage of CSF, causing an increase in ICP.
The brain compensates for increases by regulating the volume of the three substances in the following ways: limiting blood flow to the head, displacing CSF into the spinal canal, and increasing absorption or decreasing production of CSF.
Signs and Symptoms
Headache
Decreased motor strength and coordination
Seizures
Altered vital signs
Nausea and vomiting
Increased ICP
Neurologic deficits
Diplopia
Papilledema
Diagnostic Test Results
Skull CT or bone scan confirms the presence of the tumor.
Computed tomography (CT) and magnetic resonance imaging (MRI) show changes in brain tissue density.
Magnetic resonance spectroscopy evaluates the neurochemical changes in the bed of the tumor. Elevation in choline is noted in high-grade gliomas, as compared with elevated lactate levels in intracranial abscess.
Positron emission tomography evaluates the blood flow patterns in the brain and the tumor and differentiates normal brain tissue from the tumor.
The MRI or CT angiogram evaluates the arterial and venous structures surrounding the tumor.
Tissue biopsy confirms the presence of the tumor.
Lumbar puncture shows increased CSF pressure, which reflects ICP, increased protein levels, decreased glucose levels, and, occasionally, tumor cells in CSF.
CEREBRAL ANEURYSM
In an intracranial, or cerebral, aneurysm, a weakness in the wall of a cerebral artery causes localized dilation. Cerebral aneurysms usually arise at an arterial junction in the circle of Willis, the circular anastomosis connecting the major cerebral arteries at the base of the brain. Many cerebral aneurysms rupture and cause subarachnoid hemorrhage.
Causes
Congenital defect
Degenerative process such as atherosclerosis
Hypertension
Trauma
Infection
Pathophysiology
Prolonged hemodynamic stress and local arterial degeneration at vessel bifurcations are believed to be a major contributing factor to the development and ultimate rupture of cerebral aneurysms. Bleeding spreads rapidly into the subarachnoid space and commonly into the intraventricular spaces and brain tissue, producing localized changes in the cerebral cortex and focal irritation of the cranial nerves and arteries. Increased ICP occurs, causing disruption of cerebral autoregulation and alterations in cerebral blood flow. Expanding intracranial hematomas may act as space-occupying lesions compressing or displacing brain tissue. Blockage of the ventricular system or decreased CSF absorption can result in hydrocephalus. Cerebral artery vasospasm occurs in the surrounding arteries and can further compromise cerebral blood flow, leading to cerebral ischemia and cerebral infarction.
Signs and Symptoms
Cerebral aneurysms are generally asymptomatic until they rupture. Signs and symptoms of subarachnoid hemorrhage include:
change in level of consciousness
sudden-onset severe headache
photophobia
nuchal rigidity
lower back pain
nausea and vomiting
fever
positive Kernig’s sign
positive Brudzinski’s sign
seizure
cranial nerve deficits
motor weakness.
Diagnostic Test Results
Cerebral arteriogram shows the presence of a cerebral aneurysm.
Head Computed Tomography (CT) scan reveals subarachnoid hemorrhage.
Transcranial Doppler ultrasound study shows increased blood flow if vasospasm occurs.
Examination of CSF confirms bleeding.
Electrocardiogram changes reveal bradycardia, atrioventricular blocks, and premature ventricular contractions.
Complete blood count shows elevated white blood cell count.
Treatment
Bed rest in a quiet, darkened room with minimal stimulation
Surgical repair by clipping, ligation, or wrapping
Endovascular coiling
Triple H therapy (hypervolemia, hypertension, hemodilution)
Calcium channel blockers such as nimodipine
Avoidance of caffeine or other stimulants; avoidance of aspirin
Codeine or another analgesic as needed
Antihypertensives
Anticonvulsants
Sedatives
DEPRESSION
Depression is a chronic and recurrent mood disorder. Although many people may feel depressed at one time or another, clinical depression is defined when the symptoms interfere with everyday life for an extended period. It affects women twice as often as men, and it’s reported to be significantly underdiagnosed and usually inadequately treated.
Forms of depression include major depression, dysthymia, postpartum depression, premenstrual dysphoric disorder, and seasonal affective disorder.
Causes
Some people may have a genetic predisposition to developing depression.
Possible Contributing Factors
Disappointment at home, work, or school
Death of a friend or relative
Prolonged pain or having a major illness
Medical conditions, such as hypothyroidism, cancer, or hepatitis
Drugs, such as sedatives and antihypertensives
Alcohol or drug abuse
Chronic stress
Abuse or neglect
Social isolation
Nutritional deficiencies (such as folate and omega-3 fatty acids)
Sleeping problems
Pathophysiology
An imbalance of the neurotransmitters is thought to be the underlying mechanism in depression. In a person with normal levels of neurotransmitters, serotonin and norepinephrine are released from one neuron and travel to another one, activating receptors. After the receptors are activated, the neurotransmitters are taken up by the presynaptic neuron. A patient with depression has inadequate levels of serotonin or norepinephrine, thus not allowing this smooth transmission of impulses.